Banner 1900x300

SCIENTIFIC PROGRAM

  • 08:30-13:00

    Precongress Workshop

    • Session I: Male infertility epidemiology and the best medical practice based on evidence              
      Chairs: Nicolás Garrido (IVI Foundation, Spain), Craig Niederberger (USA)
    • 08:30-08:40 Introduction
      Nicolás Garrido (Spain)
    • 08:40-09:00 Male reproductive health status: a global initiative towards solving male infertility
      Chris Barratt (Scotland)
    • 09:00-09:10 Q&A
    • 09:10-09:30 Male fertility as a predictor of future health problems
      Mike Eisenberg (USA)
    • 09:30-09:40 Q&A
    • 09:40-10:00 Varicocele, what have we learned in this century?
      Ashok Agarwal (USA)
    • 10:00-10:10 Q&A
    • 10:10-10:30 How 4K-3D microscope can improve our results in male infertility surgery
      Jesse Ory (USA)
    • 10:30-10:40 Q&A
    • 10:40-11:10 Coffee break

    • Session II: The laboratory tests helping the characterization of male infertility
         
                
      Chairs: Jim Hotaling (USA) & Marga Esbert (Spain)
    • 11:10-11:30 The changes introduced by the WHO 2021 Manual and their impact and changes
      Jackson Kirkman-Brown (United Kingdom)
    • 11:30-11:40 Q&A
    • 11:40-12:00 Subtle genetic causes of male infertility beyond chromosomes
      Csilla Krausz (Italy)
    • 12:00-12:10 Q&A
    • 12:10-12:30 Exosomes in male fertility. How close we are from a clinical application?
      Alberto Pacheco (Spain)
    • 12:30-12:40 Q&A
    • 12:40-13:00 How the metrics and outcomes for male infertility research should be analysed
      Craig Niederberger (USA)
  •  13:45-14:00 Opening Ceremony
    14:00-16:00

    Ovarian stimulation

    • 14:00-14:30 Individualized approach vs “coffee for all”.
      Ernesto Bosch (Spain)
    • 14:30-15:00 Dual Stim.
      Filipo Ubaldi (Italy)
    • 15:00-15.30 Luteal phase / random start as the ideal start.
      Christophe Blockeel (Belgium)
    • 15:30-16:00    Progesterone primed ovarian stimulation.
      Baris Ata (Turkey)
    16:00-16:30 Coffee break
    16:30-18:00

    Premature Ovarian Insufficiency: What is new?     

    • 16:30-17:00 Genetics of ovarian aging and dysfunction.
      Alexandar Rajkovic (USA)
    • 17:00-17:30 How to manage the POI patient.
      Anne Gompel (France) 
    • 17:30-18:00 Reactivation of dormant ovarian follicles: an update on IVA, ASCOT and PRP.
      Nuria Pellicer (Spain)
    18:00-18:30 Coffee break
    18:30-19:30

    Debate 1: The window of implantation: does it exist?

    • What classical clinical data suggest
      Richard Paulson (USA)
    • What have we earned from modern transcriptomics
      Patricia Díaz-Gimeno (Spain)
    19:30-20:30 Industry-sponsored Symposium I
    • 08:00-10:00

      The Endometrium

      • 08:00-08:30 Endometrial immune profile: changes in an injured endometrium       
        Diana Alecsandru (Spain)
      • 08:30-09:00 Decidualization or endometrial receptivity?
        Nick Macklon (United Kingdom)
      • 09:00-09:30 Clinical option for the management of poor endometrium
        Marcos Ferrando (Spain)
      • 09:30-10:00 Impact of dysbiosis/chronic endometritris in implantation.
        TBA
      10:00-10:30 Coffee break
      10:00-12:30

      Adenomyosis  

      • 10:30-11:30 Pathophysiology.
        Serdar Bulun (USA)
      • 11:30-12:00 Ultrasound assessment.
        Caterina Exacoustos (Italy)
      • 12:00-12:30 Influence on ART outcomes.
        Mauro Cozzolino (IVIRMA, Italy)
      12:30-13:30

      Debate 2: Is diminished ovarian reserve a marker of increased aneuploidy?

      • YES
        TBA
      • NO
        Scott Morin (USA)
      13:30-14:30 Industry-sponsored Symposium II
      13:30-14:30 Lunch
      14:30-16:00

      New methods of embryo selection

      • 14:30-15:00 Fluorescence lifetime imaging: following the energy.
        Denny Sakkas (USA)
      • 15:00-15:30 Mitochondria and embryo viability: what is new?
        Emre Seli (USA)
      • 15:30-16:00 Advances in the study of culture media proteome
        TBA
      16:00-16:30 Coffee break
      16:30-18:00

      AI IN ART

      • 16:30-17:00 AI performance for embryo selection.
        Marcos Meseguer (Spain)
      • 17:00-17:30 Time to replace biopsy based PGTA with non-invasive AI based decision tools.
        Daniella Gilboa (Israel)
      • 17:30-18:00 How AI may help clinical decision making in ART.
        Antonio Urda (Spain)
      18:00-18:30

      IVI Awards Presentation

      18:30-19:00

      Debate 3: Are we discarding normal embryos using PGT-A?

      • YES
        Nobert Gleicher (USA)
      • NO
        Antonio Capalbo (Italy)
      19:00-20:00 Industry-sponsored Symposium III
    • 08:00-10:30

      Parallel Session – Embryology I

      • 08:00-08:30 Understandimg the origins of embryo aneuploidy    
        Antonio Capalbo (Italy)
      • 08:30-09:00 Transcriptomics of Androgenotes and Parthenothes in early stages of development
        Francisco Domínguez (Spain)
      • 09:00-09:30 The transcriptIonal signature of mosaic embryos
        Angel Martin (Spain)
      • 09:30-10:00 Increasing the chances of having  good embryos  to select. Embryo culture conditions
        Jason Swain (USA)
      • 10:00-10:30 Increasing the chances of having  good embryos  to select. The IVF laboratory automation
        Joseph Conaghan (USA)
      10:30-11:00 Coffee break
      11:00-13:30

      Parallel session  - Embriology II

      • 10:30-11:30 Non genetic markers of embryo quality: are them reliable enough?
        Laura Rienzi (Italy)
      • 11:30-12:00 Non invasive PGT_ How close are we to the finish
        Dagan Wells (United Kingdom)
      • 12:00-12:30 The deep learning on embryo selection
        Marcos Meseguer (Spain)
      • 12:30-13:00 Looking for a hundred per cent of accuracy
        Chaim Jalas (United Kingdom)
      • 13:00-13:30 PGT Plus  (Double Seq Methodology for Embryo selection)
        Svetlana Madjunkova (Canada)
  • 08:00-09:45

    Luteal Phase Support

    • 08:00-08:25 Differences in LP in spontaneous vs stim cycle.     
      Peter Humaidan (Denmark)
    • 08:25-08:55 LPS in the Natural/stim/HRT cycle
      Elena Labarta (Spain)
    • 08:55-09.:20 Role of CL in prevention of preeclampsia.
      Frauke von Versen-Höynck (Germany)
    • 09:20-09:45 Differences in obst/materanal outcome according to cycle preparation
      Cristina Bergh (Sweden)
    09:45-10.15 Coffee break
    10:15-11:30

    Recurrent implantion failure 

    • 10:15-10:40 The clinician perspective.
      Jesse Ory (USA)
    • 10:40-11:05 The IVF lab point of view
      Maria José de los Santos (Spain)
    • 11:05-11:30 The psycologist approach
      Jacky Boivin (United Kingdom)
    11:30-12:45

    Future Perspectives

    • 11:30-11.55 Mechanisms governing human ovarian aging
      Juan Carlos Izpisua Belmonte (USA)
    • 11.55-12.20 Strategies to repair damaged oocytes.
      Sonia Herráiz (Spain)
    • 12.20-12:45 Creating spermatozoa
      Jim Hotaling (USA)

CEST time